Bristol-Myers Squibb Company
DE ˙ XTRA ˙ US1101221083
47,43 € ↓ -0,01 (-0,01%)
2026-06-04
DEL PRIS
SecurityDE:BRM / Bristol-Myers Squibb Company
InstitutionImpax Asset Management Group plc
Latest Disclosed Ownership103,727 shares
Latest Disclosed Value $ 6,291,043
Impax Asset Management Group plc reports 28.30% decrease in ownership of BRM / Bristol-Myers Squibb Company

On May 12, 2026 - Impax Asset Management Group plc filed a 13F-HR form disclosing ownership of 103,727 shares of Bristol-Myers Squibb Company (DE:BRM) valued at $5,437,369 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 29, 2026 disclosing 144,677 shares of Bristol-Myers Squibb Company. This represents a change in shares of -28.30% during the quarter. The current value of the position is $4,919,772 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-12 2026-03-31 13F Bristol-Myers Squibb Common Stock 110122108 103,727 -40,950 -28.30 6,291 -19.38 0.0439
2026-01-29 2025-12-31 13F Bristol-Myers Squibb Common Stock 110122108 144,677 -3,367 -2.27 7,804 16.88 0.0488
2025-11-06 2025-09-30 13F Bristol-Myers Squibb Common Stock 110122108 148,044 -4,251 -2.79 6,677 -5.29 0.0390
2025-08-08 2025-06-30 13F Bristol-Myers Squibb Common Stock 110122108 152,295 20,864 15.87 7,050 -12.05 0.0405
2025-04-29 2025-03-31 13F Bristol-Myers Squibb Common Stock 110122108 131,431 -16,815 -11.34 8,016 -4.40 0.0483
2025-02-04 2024-12-31 13F Bristol-Myers Squibb Common Stock 110122108 148,246 -100,826 -40.48 8,385 -34.94 0.0380
2024-11-06 2024-09-30 13F/A-1 Bristol-Myers Squibb Common Stock 110122108 249,072 -2,574 -1.02 12,887 23.31 0.0507
2024-10-30 2024-09-30 13F Bristol-Myers Squibb Common Stock 110122108 249,072 -2,574 12,887 0.0508
2024-11-08 2024-06-30 13F/A-1 Bristol-Myers Squibb Common Stock 110122108 251,646 -996 -0.39 10,451 -23.72 0.0425
2024-08-05 2024-06-30 13F Bristol-Myers Squibb Common Stock 110122108 251,646 -996 10,451 0.0426
2024-04-30 2024-03-31 13F Bristol-Myers Squibb Common Stock 110122108 252,642 66,792 35.94 13,701 43.68 0.0524
2024-01-26 2023-12-31 13F Bristol-Myers Squibb Common Stock 110122108 185,850 -92,216 -33.16 9,536 -40.92 0.0383
2023-11-07 2023-09-30 13F/A-1 Bristol-Myers Squibb Common Stock 110122108 278,066 -7,511 -2.63 16,139 -11.63 0.0721
2023-11-07 2023-09-30 13F Bristol-Myers Squibb Common Stock 110122108 278,066 16,139
2023-08-07 2023-06-30 13F Bristol-Myers Squibb Common Stock 110122108 285,577 -402,674 -58.51 18,263 -61.72 0.0734
2023-05-10 2023-03-31 13F Bristol-Myers Squibb Common Stock 110122108 688,251 36,679 5.63 47,703 1.75 0.1993
2023-02-09 2022-12-31 13F Bristol-Myers Squibb Common Stock 110122108 651,572 127,114 24.24 46,881 25.74 0.2098
2022-11-08 2022-09-30 13F Bristol-Myers Squibb Common Stock 110122108 524,458 156,789 42.64 37,284 31.69 0.1916
2022-08-11 2022-06-30 13F/A-2 Bristol-Myers Squibb Common Stock 110122108 367,669 -263,726 -41.77 28,311 -38.60 0.1380
2022-08-02 2022-06-30 13F Bristol-Myers Squibb Common Stock 110122108 631,395 0 46,111 0.1906
2022-05-16 2022-03-31 13F Bristol-Myers Squibb Common Stock 110122108 631,395 -78,223 -11.02 46,111 4.22 0.1906
2022-02-14 2021-12-31 13F Bristol-Myers Squibb Common Stock 110122108 709,618 65,395 10.15 44,244 16.07 0.1618
2021-11-12 2021-09-30 13F Bristol-Myers Squibb Common Stock 110122108 644,223 80,722 14.33 38,119 1.24 0.1566
2021-08-05 2021-06-30 13F Bristol-Myers Squibb Common Stock 110122108 563,501 0 0.00 37,653 5.84 0.1660
2021-05-14 2021-03-31 13F Bristol-Myers Squibb Common Stock 110122108 563,501 152,621 37.14 35,574 39.58 0.1820
2021-02-16 2020-12-31 13F Bristol-Myers Squibb Common Stock 110122108 410,880 0 0.00 25,487 2.89 0.1622
2020-11-12 2020-09-30 13F Bristol-Myers Squibb Common Stock 110122108 410,880 60,000 17.10 24,772 20.07 0.2167
2020-08-14 2020-06-30 13F Bristol-Myers Squibb Common Stock 110122108 350,880 0 0.00 20,632 5.49 0.2117
2020-05-15 2020-03-31 13F Bristol-Myers Squibb Common Stock 110122108 350,880 62,800 21.80 19,558 5.76 0.2602
2020-02-13 2019-12-31 13F Bristol-Myers Squibb Common Stock 110122108 288,080 12,868 4.68 18,492 32.50 0.2063
2019-11-14 2019-09-30 13F Bristol-Myers Squibb Common Stock 110122108 275,212 0 0.00 13,956 11.82 0.1818
2019-08-13 2019-06-30 13F Bristol-Myers Squibb Common Stock 110122108 275,212 83,200 43.33 12,481 36.24 0.1621
2019-05-13 2019-03-31 13F Bristol-Myers Squibb Common Stock 110122108 192,012 192,012 9,161 0.1261
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.